Question on the Use of Composite Outcomes vs. All-Cause Mortality in Drug Trials
|
|
5
|
57
|
May 16, 2025
|
Progression in cancer trials
|
|
26
|
5698
|
June 25, 2024
|
A randomized trial of epinephrine in out-of-hospital cardiac arrest
|
|
13
|
9871
|
September 27, 2022
|
When exactly does `sustained clinical recovery' occur?
|
|
6
|
2379
|
June 13, 2022
|
Extensions of 'worst-rank' score methods with outcomes truncated by death
|
|
13
|
3578
|
September 2, 2021
|
Ordinal outcomes in survival analysis
|
|
3
|
4724
|
January 15, 2021
|
Deviation in primary endpoint definition
|
|
12
|
7462
|
July 26, 2019
|
Joint models for longitudinal and time-to-event data analysis applied to RCTs
|
|
7
|
8011
|
April 22, 2019
|
Cumulative toxicity endpoint opinion
|
|
3
|
4416
|
March 5, 2019
|
Question on modeling repeated outcomes among single patients
|
|
9
|
7561
|
November 7, 2018
|
Examining the 'penumbra theory' via NINDS reanalysis
|
|
6
|
7012
|
September 20, 2018
|